X Ray News and Research

RSS

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.

8 May 2014

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects-pancreatitis or fistula formation-after undergoing percutaneous CT-guided irreversible electroporation (IRE)-a nonthermal ablation technology that is safe near vascular and ductal structures-as a therapy.

8 May 2014

Breast tomosynthesis after mammography screening may lessen use of biopsies, ultrasound

Breast tomosynthesis in the diagnostic workup for one- or two-view focal asymmetry detected at screening mammography resulted in less use of ultrasound, fewer biopsies, and higher positive predictive value for cancer than when diagnostic exams involved only 2D mammography, according to a study conducted at the University of Virginia.

8 May 2014

Patients undergoing peritoneal dialysis catheter placement experience fewer complications

Patients undergoing peritoneal dialysis catheter placement via fluoroscopy and ultrasound-guidance experienced significantly fewer complications at 1 year post-insertion than did patients whose catheters were placed laparoscopically.

8 May 2014

Dose-tracking software provides easy monitoring of radiation dose exposure in academic practice

Dose-tracking software provides effective and easy monitoring of radiation dose exposure in a busy academic practice, according to research conducted at Massachusetts General Hospital.

8 May 2014

Misinformation about radiation exposure may result in avoidance of screening mammography

Misinformation and misunderstanding about the risks associated with ionizing radiation create heightened public concern and fear, and may result in avoidance of screening mammography that can detect early cancers.

8 May 2014

BIOTRONIK's Entovis pacemaker system gets FDA approval

BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.

7 May 2014

Retiring Ore. exchange official lashes out at state leaders

Developments with online insurance marketplaces in Nevada, Oregon and New Mexico are also examined. Tom Jovick retired this week as a Cover Oregon administrator. On his way out, he issued a stinging letter to his fellow Cover Oregon staffers condemning the state's reaction to the IT crisis and saluting the worker bees for carrying on under heavy duress.

5 May 2014

TSRI scientists discover new HIV target

A team led by scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by human antibodies in a way that neutralizes the infectivity of a wide variety of HIV strains.

25 Apr 2014

LA BioMed researcher wins Ray E. Helfer Award for contributions to detection, prevention of child abuse

Carol D. Berkowitz, MD, a Los Angeles Biomedical Research Institute lead researcher, was recently honored for her distinguished contributions to the detection and prevention of child abuse and neglect by the Ray E. Helfer Society, a national organization of physicians devoted to the problem of maltreated children.

25 Apr 2014

NeuroPhage engineers series of molecules with potential to treat most neurodegenerative diseases

Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.

23 Apr 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.

22 Apr 2014

Sprifermin reduces cartilage loss in patients with knee osteoarthritis

In a new study in patients with osteoarthritis (OA) of the knee, at 12 months, total femorotibial cartilage thickness loss was reduced in sprifermin (recombinant human fibroblast growth factor 18)-treated knees compared to placebo-treated knees, with effects being significant in the lateral femorotibial compartment but not in the central femorotibial compartment.

18 Apr 2014

XBiotech announces results from Phase I/II oncology study

XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix™, XBiotech's novel, non-cytotoxic, anti-tumor therapy.

18 Apr 2014

New research may help scientists develop treatments or vaccines for Dengue fever

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other disease-causing flaviviruses.

18 Apr 2014

Research provides fresh insight into structure of sodium channels

Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.

18 Apr 2014

Research report on global teleradiology market

Global Information Inc. announces the addition of a new market research report "Teleradiology Market (X-ray, Ultrasound, CT, MRI and Nuclear Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" at GIIResearch.com

17 Apr 2014

X Ray News and Research

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

Breast tomosynthesis after mammography screening may lessen use of biopsies, ultrasound

Patients undergoing peritoneal dialysis catheter placement experience fewer complications

Dose-tracking software provides easy monitoring of radiation dose exposure in academic practice

Misinformation about radiation exposure may result in avoidance of screening mammography

BIOTRONIK's Entovis pacemaker system gets FDA approval

Retiring Ore. exchange official lashes out at state leaders

TSRI scientists discover new HIV target

LA BioMed researcher wins Ray E. Helfer Award for contributions to detection, prevention of child abuse

NeuroPhage engineers series of molecules with potential to treat most neurodegenerative diseases

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sprifermin reduces cartilage loss in patients with knee osteoarthritis

XBiotech announces results from Phase I/II oncology study

New research may help scientists develop treatments or vaccines for Dengue fever

Research provides fresh insight into structure of sodium channels

Research report on global teleradiology market

John Hopkins researchers create novel optical imaging equipment for use on SARRP research platform

Special supplement explores the causes of distracted driving among teens

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo